Peptide Therapeutics Information Service Package

Publisher: La Merie Publishing
Format: Online Database and PDF
Product Line:
Competitor Analysis
Product Code: LMDB0012
Release Date: November of 2014

2,400.00 €
(Discount: 50.00%)
1,200.00 €
Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Peptide Therapeutics Information Service Package

This Informatiom Service Package about Peptide Therapeutics consists of five Competitor Analysis reports about peptide therapeutics and a 1-year subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database with 27/7 online access. Credentials to access the database as well as the five Competitor Analysis reports in pdf format will be sent by e-mail within 24 hours after purchase. This package represents a 50% cost saving over list prices.

Peptide Therapeutics Pipeline Database: 1-Year Subscription

Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files.

Each project (file) is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic peptides is intuitive. Data sets of interest can be printed and exported in Word or Excel format. Projects are being updated continuously by passive and active searches. Information from press releases is entered on a daily basis. Active searches for targets, indications, company pipelines, scientific congresses, corporate releases, publications and in other sources are conducted on a rotating, regular basis.
The R&D history of each project with online references of information sources can be viewed and printed. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases.

An advanced search function allows to combine search parameters. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, therapeutic area or company name. Sample screenshots illustrate the database.

See our sample screenshots of the database: Download sample screenshots

Prerequisit: Internet access

Competitor Analysis reports

Each of the five Competitive Intelligence Report about peptides therapeutics provides a competitor analysis in the product portfolios and development pipelines of peptide therapeutics in specific therapeutic segment:

  • Anti-Infective Peptides
  • Anti-Inflammatory Peptides
  • Cardiovascular Peptides
  • Cardiometabolic Peptides
  • Cancer Peptides

Each of the reports provides a compilation of currently major marketed peptide products and active projects in research and development for the specific therapeutic segment. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes
  • Target / Mechanism of Action
  • Class of Compound
  • Company
  • Product Category
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

Purchase of the Peptide Therapeutics Information Service Package includes a report on the 2013 Sales of Major Peptide Therapeutics.


Peptide Therapeutics Information Service Package

Tables of Contents of the five Competitor Analysis reports about peptide therapeutics:

Competitor Analysis: Anti-Infective Peptides

  • 2013 Sales of Major Anti-Infective Peptides
  • Anti-Bacterial Peptides
  • Anti-Fungal Peptides
  • Anti-Viral Peptides
  • Corporate Anti-Infective Peptide R&D Pipelines

Competitor Analysis: Anti-Inflammatory Peptides

  • 2013 Sales of Major Anti-Inflammatory Peptides
  • Cardiovascular Diseases
  • Dermatological Diseases
  • Gastrointestinal Diseases
  • Neurological Diseases
  • Ophthalmological & Otorhino Diseases
  • Pulmonary & Respiratory Diseases
  • Renal Diseases
  • Rheumatological & Autoimmune Diseases
  • Transplantation
  • Not-Specified Inflammatory & Autoimmune Diseases
  • Corporate Anti-Inflammatory Peptide R&D Pipelines

Competitor Analysis: Cardiovascular Peptides

  • 2013 Sales of Major Cardiovascular Peptides
  • Acute Care & Reperfusion Injuries
  • Heart Failure
  • Coronary Ischemia & Myocardial Infarction
  • Cardiometabolic Disease & Atherosclerosis
  • Peripheral Vascular Disease
  • Hypertension
  • Pulmonary Artery Hypertension
  • Hemostasis, Wound Sealing & Prevention of Thrombosis
  • Hematologic Diseases
  • Corporate Cardiovascular Peptide R&D Pipelines

Competitor Analysis: Cardiometabolic Peptides

  • 2013 Sales of Major CardioMetabolic Peptides
  • Selective Peptide GLP-1 Receptor Agonists for CardioMetabolic Diseases
  • Dual Target Peptide GLP-1 Agonists for CardioMetabolic Diseases
  • Other Peptides for Diabetes
  • Other Peptides for Obesity & Lipodystrophy
  • Other Peptides for Diabetes and Obesity & Cardiometabolic Disease
  • Peptides for Atherosclerosis
  • Corporate Cardiometabolic Peptide R&D Pipelines

Competitor Analysis: Cancer Peptides

  • 2013 Sales of Major Cancer Peptides
  • Somatostatin Analogs
  • GnRH Analogs: Agonists
  • GnRH Analogs: Antagonists
  • Targeted Cancer Peptides: Proteasome Inhibition
  • Targeted Cancer Peptides: HDAC Inhibition
  • Cytotoxic, Cytostatic or Apoptotic Cancer Peptides
  • Cancer Peptide-Drug Conjugates and Peptide Fusion Proteins
  • Other Cancer Peptides
  • Corporate Cancer Peptide R&D Pipelines

The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing